Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Teva Pharmaceuticals Industries
Woman and Man Max 99 years
Teva Pharmaceuticals Industries LtD
Update Il y a 4 ans
Dose finding study to evaluate the pharmacodynamics, pharmacokinetics, efficacy and safety of balugrastim in pediatric patients diagnosed with solid tumors receiving chemotherapy. Dóziskereső vizsgálat, amely a balugrastim farmakodinámiáját, farmakokinetikáját, hatásosságát és biztonságosságát kutatja szolid tumorral diagnosztizált, és kemoterápiás kezelésben részesülő gyermek betegek esetében
The primary objective of this study is to find the optimal dose of balugrastim by characterizing its pharmacokinetics (PK), and by comparing the pharmacodynamics (PD) of balugrastim to filgrastim duri...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Teva Pharmaceuticals Industries LtD
Update Il y a 4 ans
A Multicenter, Double-Blind, Randomized Start, Placebo-Controlled, Parallel-Group Study to Assess Rasagiline as a Disease Modifying Therapy in Early Parkinson’s Disease Subjects. Estudio multicéntrico, doble ciego, de inicio randomizado, controlado con placebo, de grupos paralelos, para valorar Rasagilina como una terapia que modifica la enfermedad de Parkinson en pacientes con enfermedad de Parkinson en fase temprana
To assess rasagiline as a disease modifying therapy in early PD
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man
Between 18 years
and 99 years
Teva Pharmaceuticals Industries
Update Il y a 4 ans
Étude C41443-2057 : étude de phase 1-2 non-randomisée visant à évaluer la pharmacocinétique, la sécurité et l’efficacité de l’omacétaxine mépésuccinate administré par voie sous-cutanée chez des patients ayant une leucémie myéloïde chronique en phase chronique ou accélérée avec échec de plus de 2 thérapies par des inhibiteurs de tyrosine kinases. [essai clos aux inclusions]
La leucémie myéloïde aiguë résulte des mutations acquises dans l’ADN de cellule de la moelle osseuse en développement. Cette cellule devient leucémique et se multiplie de façon incontrôlable, donnant ...
Country
France
organs
Leucémies chroniques
Specialty
Chimiothérapie
Essai clos aux inclusions
More information
Man
Between 18 years
and 99 years
Teva Pharmaceuticals Industries
Update Il y a 4 ans
SYNERGY : Essai de phase 3 randomisé comparant l’efficacité d’un traitement associant ou non le docétaxel et la prednisone à du custirsen (OGX-011), chez des patients ayant un cancer de la prostate métastatique hormono-résistant. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
L’objectif de cet essai est d’évaluer si l’adjonction du custirsen au traitement de référence par docétaxel et prednisone prolonge la survie des patients ayant un cancer de la prostate métastatique ho...
Country
France
organs
Prostate
Specialty
Thérapies Ciblées
,
Chimiothérapie
Essai clos aux inclusions
More information
Woman and Man Max 99 years
Teva Pharmaceuticals Industries LtD
Update Il y a 4 ans
A PHASE I, DOUBLE BLIND, PLACEBO CONTROLLED, RANDOMIZED (WITHIN EACH GROUP) STUDY TO EVALUATE THE INTERACTION BETWEEN ORALLY ADMINISTERED TYRAMINE HYDROCHLORIDE AND RASAGILINE MESILATE IN HEALTHY SUBJECTS
To assess tyramine sensitivity when administered with rasagiline, and the selectivity of rasagiline for monoamine oxidase type B (MAO-B)
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
MicroDose Therapeutx, Inc., a wholly owned subsidiary of Teva Pharmaceuticals Industries, Ltd
Update Il y a 4 ans
This is a trial that is studying a new inhaled medicine, MDT-637, that is being researched for the treatment of a viral infection of the lungs that typically affects the young and the elderly (Respiratory Syncytial Virus, RSV). Adult volunteers will be infected with RSV (the infection is typically mild in adults), half of these volunteers will be treated with MDT-637, and the other half will receive placebo which has no effect on RSV
The primary efficacy objective and endpoint of the study is to evaluate the antiviral effect (as defined by reduction in AUC of viral load) of aerosolized MDT-637, in a manner which mimics the timing ...
Country
None
organs
None
Specialty
None
unknown
More information